PeriGen, an innovator of perinatal early warning systems unveiled their new artificial intelligence powered fetal and maternal early warning solution, Periwatch at HIMSS18. PeriWatch™ Vigilance is a new early warning platform for obstetrics that automatically identifies patients whose conditions are worsening, facilitating more timely interventions.
Vigilance augments currently installed fetal surveillance systems, providing a critical layer of patient safety without requiring a hospital to “rip and replace” current systems. The “always on” software uses proprietary intelligent algorithms to analyze maternal vital signs, fetal heart rate, contractions and labor progress in real time, informing clinicians of emerging abnormalities. Specific thresholds and automated checklists can be configured according to each institution’s preferences.
PeriWatch Vigilance is an enterprise-wide platform that is simple to implement and augments current fetal surveillance systems, providing a critical layer of patient safety with minimal IT investment and management. Automated analysis and clear patient identification of worsening conditions are essential for centers providing virtual clinical support for hundreds of remote sites.
PeriGen recently inked a strategic reseller agreement with Qualcomm Incorporated through its wholly owned subsidiary, Qualcomm Life, Inc.